The global Sodium Citrate Blood Specimen Collection Tubes Market is anticipated to witness a CAGR of 7.6% from 2021 to 2028.

The procedure of taking blood samples from patients before they are examined in the laboratory is known as blood specimen collection in lab. It is based on the most well-known premise, the "order of draw." Different types of sample collection tubes are required for different testing and biochemical procedures. The purpose of color-coding tubes is to make them easier to identify. The "citrate tube" is used to collect blood for coagulation testing. As an anticoagulant, it includes 3.2 percent sodium citrate. To create plasma, it's also a good idea to mix the blood inside the tube a few times. Most blood collection tubes contain an additive that either speeds up (clot activator) or stops blood from clotting (clot inhibitor) (anticoagulant). A tube containing a clot activator will yield a serum sample, while a tube containing an anticoagulant will yield a plasma sample when blood is separated by centrifugation. Some tests necessitate the use of serum, while others necessitate the use of plasma, and still, others necessitate the use of anticoagulated whole blood.

Market Dynamics

The demand for sodium citrate blood specimen collection tubes skyrocketed due to the arrival of the COVID-19 pandemic. Blood specimens are used for antibody (or serological) testing, and specimens are obtained by pricking the skin using a fingerstick device for some tests allowed by the US Food and Drug Administration that are utilized at the point of care. Because of a spike in demand during the COVID-19 public health emergency and recent vendor supply issues, the Food and Drug Administration (FDA) is aware that the United States is experiencing severe interruptions in the availability of numerous blood specimen collection (blood draw) tubes. The FDA is adding all blood specimen collecting tubes to its medical equipment shortage list. On June 10, 2021, the FDA sent a letter to health care and laboratory employees informing them of a sodium citrate blood specimen collection (light blue top) tube shortage.

An increase in the number of blood clot cases worldwide drives the industry demand. When a blood artery is injured, blood clotting, or coagulation, is a vital mechanism that avoids excessive bleeding. Blood clotting, or coagulation, is a critical mechanism that prevents excessive bleeding when a blood artery is ruptured. Deep vein thrombosis (DVT) is a clot that originates in a main vein of the leg or, pelvis, less usually in the arms, or some large veins in the body. A clot in a vein can sometimes detach from its source and travel via the heart to the lungs, where it becomes immovable, and blocking proper blood flow. As said by the American Society of Hematology, deep vein thrombosis affects up to 900,000 persons in the US each year, killing more than 100,000 people Despite its widespread occurrence, the community is typically uninformed of DVT/risk PE's causes and symptoms.

Market Insights

The global sodium citrate blood specimen collection tubes market is divided into two segments: end-user and region. The end-user segmentation includes hospitals, medical clinics, diagnostic centers, and others. Due to the increased demand for sodium citrate blood specimen collection tubes to collect, transfer, and store blood samples for coagulation testing, hospitals accounted for the majority of the market share in 2020. Long-term consequences (post-thrombotic syndrome) afflict one-third to one-half of patients who have had a DVT. These include discomfort, edoema, scaling, and discoloration, in the affected limb. Within ten years, one-third of persons with DVT/PE will have a recurrence (about 33 percent). About 5 to 8% of the population in the United States has one of the numerous genetic risk factors, commonly known as hereditary thrombophilias, in which a genetic flaw raises the risk of thrombosis.

Global Sodium Citrate Blood Specimen Collection Tubes Market Geographical Analysis

North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa are the segmentation of the global sodium citrate blood specimen collection tubes industry. Among all the regions, Asia-Pacific conquered the maximum market share in 2020 and is likely to continue its trend during the predicted years 2021 - 2028. In the Asia-Pacific, notably in India, rising incidences for cardiac-related illnesses is quite widespread, which is expected to spur the demand for the industry. In addition, the rise in prevalence of blood clotting disorders in the Asia Pacific region is also expected to boost the market demand in the coming years.

Global Sodium Citrate Blood Specimen Collection Tubes Industry Segment Analysis

End-User Segments

·         Hospitals

·         Diagnostic Centers

·         Medical Clinics

·         Others

Sodium Citrate Blood Specimen Collection Tubes Market Top Companies

The major players in the market are identified in this section of the report. AdvaCare Pharma Becton Dickinson (BD), CML Biotech (P) Ltd., Laboratory Corporation of America®, Greiner Bio-One International GmbH, Neu Micromed International Pvt. Ltd., and FL MEDICAL s.r.l. are the leading players profiled in the research report.

Sodium Citrate Blood Specimen Collection Tubes Market Regions